Salvage focal ablative therapy for radio-recurrent prostate cancer is safe and provides good short to medium-term oncological control
June 3, 2020
SonaCare Medical announces new study results that shows focal ablative salvage therapy after radio-recurrent prostate cancer is safe and provides good cancer control over 6 years.
Associated Urological Specialists Partners with Vituro Health to Offer HIFU Treatment for Prostate Cancer
February 20, 2020
HIFU technology will soon be available for prostate cancer patients in the Chicago area through the AUS’s partnership with Vituro Health.
Vituro Health Successfully Completes First TULSA-PRO® Cases in the United States Following FDA 510(K) Clearance
February 4, 2020
Vituro Health is pleased to announce that it, in partnership with Choice Diagnostic Imaging, successfully completed the first three TULSA-PRO® treatments to ablate prostate tissue in patients recently diagnosed with Prostate Cancer.
August 27, 2019
The partnership will allow Vituro Health physicians to offer the customizable, incision-free, radiation-free TULSA-PRO® to patients for prostate tissue ablation